"Attention of the Holders of Securities in Physical Mode is invited to Circular No. SEBI/HO/MIRSD/PoD-1/P/CIR/2023/181 dated November 17, 2023 issued by SEBI."
Home
About Us
Company Profile
Corporate ETHOS
Mission
Vision
Board of Directors and KMPs
Board Committees
Products
Speciality Chemicals
Skin Care Products
Hospital Care Products
Generics
Investors
Financial Information
Investor Information
Annual Reports
Shareholding Pattern
Corporate Governance
Policies
Other Data
Newsapaper Publication
Shareholders Meetings/Other Disclosures
Disclosure under Reg 46 of SEBI (LODR) Regulations 2015.
Media
News & Press Release
Contact Us
Q1
Closure of Trading Window
Revised Compliance Certificate For Regulation 40(10) For The Year Ended March, 2022.
Submission Of Half Yearly Disclosure On Related Party Transactions
Audited Financial Results For The Quarter And Year Ended 31 March, 2022.
Board Meeting Intimation for Approval Of Audited Financial Results For The Quarter And Financial Year Ended 31.03.2022
Compliance Certificate For Regulation 40(9) For The Year Ended March, 2022.
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliance Certificate For The Year Ended March, 2022.
Home
About Us
Company Profile
Corporate ETHOS
Mission
Vision
Products
Personal Care Ingredients
Generics Ingredients
Hospital Care Products
Sking Care Products
Investors
Financial Information
Board of Directors
Annual Reports
Listing Updates
Shareholding Pattern
Corporate Governance
Half Yearly Compliances
Media
News & Press Release
Corporate Announcement
Gallery
Contact Us
